PERKINS CAPITAL MANAGEMENT INC
13F Reported Value
ⓘ$106.7M
Holdings
86
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
PERKINS CAPITAL MANAGEMENT INC disclosed 86 positions worth $106.7M in its Form 13F-HR for Q1 2026, led by $NTRA (Natera, Inc.) at 8.3% of the equity portfolio, followed by $LLY and $AXGN. During the quarter the fund opened 4 new positions and exited 9 — including a new stake in $TLSI and a full exit from $APPS. The portfolio is most concentrated in Healthcare (63.3% of disclosed assets). All figures are sourced directly from PERKINS CAPITAL MANAGEMENT INC’s Form 13F-HR filing with the SEC under CIK 884300.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 46.4#1,659
Quality
$8.9M44,300 sh - 89.3#2
Quality
$8.1M8,830 sh - 38.0#2,028
Quality
$5.6M168,842 sh - 73.6
Quality
$5.5M9,700 sh - 83.7
Quality
$4.2M11,415 sh - 29.5
Quality
$3.8M930,930 sh - 70.7
Quality
$3.4M6,300 sh - —
Quality
$3.4M1,476,441 sh - 78.8
Quality
$3.2M15,504 sh - —
Quality
$2.9M306,706 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 46.4#1,659 | $8.9M | 44,300 | |
| 89.3#2 | $8.1M | 8,830 | |
| 38.0#2,028 | $5.6M | 168,842 | |
| 73.6 | $5.5M | 9,700 | |
| 83.7 | $4.2M | 11,415 | |
| 29.5 | $3.8M | 930,930 | |
| 70.7 | $3.4M | 6,300 | |
| — | $3.4M | 1,476,441 | |
| 78.8 | $3.2M | 15,504 | |
| — | $2.9M | 306,706 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of PERKINS CAPITAL MANAGEMENT INC's 86 positions.
Showing top 10 of 86 holdings.
Sector Allocation
Healthcare
$67.5M
Technology
$30.0M
Communication Services
$2.5M
Financials
$2.0M
Materials
$1.6M
Energy
$1.3M
Consumer Discretionary
$930,280
Industrials
$490,304
Full Holdings — PERKINS CAPITAL MANAGEMENT INC (Q1 2026)
All 86 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Natera, Inc. | $8.9M | 8.3% | -1% | 46.4 | |
| 2 | ELI LILLY & Co | $8.1M | 7.6% | -2% | 89.3 | |
| 3 | Axogen, Inc. | $5.6M | 5.2% | -26% | 38 | |
| 4 | IDEXX LABORATORIES INC /DE | $5.5M | 5.1% | +0% | 73.6 | |
| 5 | MICROSOFT CORP | $4.2M | 4.0% | -7% | 83.7 | |
| 6 | Butterfly Network, Inc. | $3.8M | 3.5% | +1% | 29.5 | |
| 7 | CIENA CORP | $3.4M | 3.2% | +0% | 70.7 | |
| 8 | MDxHealth SA | $3.4M | 3.2% | +7% | — | |
| 9 | ADVANCED MICRO DEVICES INC | $3.2M | 3.0% | -12% | 78.8 | |
| 10 | QUICKLOGIC Corp | $2.9M | 2.7% | +11% | — | |
| 11 | LEMAITRE VASCULAR INC | $2.8M | 2.6% | -11% | 69.1 | |
| 12 | OOMA INC | $2.6M | 2.5% | -1% | 51.1 | |
| 13 | VERACYTE, INC. | $2.4M | 2.3% | -0% | 59.5 | |
| 14 | ABBOTT LABORATORIES | $2.1M | 2.0% | -4% | 67 | |
| 15 | Alphatec Holdings, Inc. | $1.9M | 1.8% | +0% | 37.7 | |
| 16 | Ondas Inc. | $1.8M | 1.7% | -0% | 31.8 | |
| 17 | Cryoport, Inc. | $1.7M | 1.6% | -0% | 59.7 | |
| 18 | NEOGEN CORP | $1.7M | 1.6% | -1% | 36.9 | |
| 19 | Perion Network Ltd. | $1.6M | 1.5% | +13% | — | |
| 20 | Personalis, Inc. | $1.5M | 1.4% | +0% | 15.7 | |
| 21 | MAGNITE, INC. | $1.4M | 1.3% | -2% | 42.6 | |
| 22 | Lucid Diagnostics Inc. | $1.3M | 1.2% | +0% | — | |
| 23 | Inogen Inc | $1.2M | 1.2% | -8% | 35.5 | |
| 24 | Inuvo, Inc. | $1.2M | 1.1% | -1% | 35.2 | |
| 25 | Crexendo, Inc. | $1.2M | 1.1% | +0% | 59.7 | |
| 26 | Backblaze, Inc. | $1.2M | 1.1% | +22% | 36.9 | |
| 27 | AbbVie Inc. | $1.2M | 1.1% | -9% | 59.3 | |
| 28 | NEUROONE MEDICAL TECHNOLOGIES Corp | $1.1M | 1.1% | +0% | — | |
| 29 | PFIZER INC | $1.0M | 0.9% | -4% | 69 | |
| 30 | GILEAD SCIENCES, INC. | $1.0M | 0.9% | -13% | 77.8 | |
| 31 | NEOGENOMICS INC | $982,037 | 0.9% | -7% | 34.6 | |
| 32 | Merck & Co., Inc. | $932,247 | 0.9% | -11% | 70.9 | |
| 33 | TriSalus Life Sciences, Inc. | $920,404 | 0.9% | NEW | 28.3 | |
| 34 | Zeta Global Holdings Corp. | $889,928 | 0.8% | -1% | 53.6 | |
| 35 | Safe Pro Group Inc. | $881,062 | 0.8% | NEW | — | |
| 36 | TELA Bio, Inc. | $879,363 | 0.8% | +1% | 24.9 | |
| 37 | CODEXIS, INC. | $859,825 | 0.8% | -0% | 11.3 | |
| 38 | Usio, Inc. | $800,202 | 0.8% | -1% | 35.3 | |
| 39 | ELUTIA INC. | $794,738 | 0.7% | -3% | — | |
| 40 | CPS TECHNOLOGIES CORP/DE/ | $750,187 | 0.7% | -1% | 40.5 | |
| 41 | AtriCure, Inc. | $744,633 | 0.7% | -5% | 47.6 | |
| 42 | Viatris Inc | $741,631 | 0.7% | -5% | 47.1 | |
| 43 | Profound Medical Corp. | $740,534 | 0.7% | +0% | — | |
| 44 | SkyWater Technology, Inc | $723,624 | 0.7% | -80% | 68 | |
| 45 | BlackSky Technology Inc. | $723,350 | 0.7% | +0% | 15.7 | |
| 46 | Apple Inc. | $672,543 | 0.6% | -43% | 76.1 | |
| 47 | US BANCORP DE | $652,725 | 0.6% | +0% | 71.4 | |
| 48 | BIODESIX INC | $649,353 | 0.6% | +0% | 32.3 | |
| 49 | CONOCOPHILLIPS | $640,200 | 0.6% | -8% | 74.8 | |
| 50 | Celcuity Inc. | $616,356 | 0.6% | -16% | — | |
| 51 | ANI PHARMACEUTICALS INC | $602,972 | 0.6% | -7% | 68.6 | |
| 52 | TARGET CORP | $593,880 | 0.6% | +0% | 53.1 | |
| 53 | Beeline Holdings, Inc. | $575,750 | 0.5% | +0% | — | |
| 54 | Owlet, Inc. | $545,328 | 0.5% | +4% | 32.5 | |
| 55 | AT&T INC. | $463,608 | 0.4% | -29% | 71.9 | |
| 56 | VERIZON COMMUNICATIONS INC | $457,221 | 0.4% | -17% | 71.6 | |
| 57 | BRISTOL MYERS SQUIBB CO | $450,629 | 0.4% | -12% | 70.1 | |
| 58 | BP PLC | $432,400 | 0.4% | +0% | — | |
| 59 | DONALDSON Co INC | $390,402 | 0.4% | +5% | 64.7 | |
| 60 | CASTLE BIOSCIENCES INC | $378,438 | 0.3% | -45% | 37.7 | |
| 61 | EPLUS INC | $376,250 | 0.3% | +0% | 56 | |
| 62 | NXP Semiconductors N.V. | $354,348 | 0.3% | -22% | — | |
| 63 | DIGI INTERNATIONAL INC | $353,450 | 0.3% | +0% | 56.3 | |
| 64 | FASTENAL CO | $336,400 | 0.3% | +0% | 73.5 | |
| 65 | Vericel Corp | $336,176 | 0.3% | -2% | 46 | |
| 66 | GENERAL MILLS INC | $330,327 | 0.3% | -15% | 64.1 | |
| 67 | Elauwit Connection, Inc. | $329,115 | 0.3% | +0% | — | |
| 68 | Lifevantage Corp | $325,978 | 0.3% | +0% | 49.6 | |
| 69 | Veritone, Inc. | $309,782 | 0.3% | -10% | 13.2 | |
| 70 | JOHNSON & JOHNSON | $293,328 | 0.3% | -25% | 72.8 | |
| 71 | BIOLIFE SOLUTIONS INC | $238,500 | 0.2% | +0% | 41.7 | |
| 72 | Seagate Technology Holdings plc | $215,468 | 0.2% | NEW | — | |
| 73 | EXAGEN INC. | $215,388 | 0.2% | +287% | 25.2 | |
| 74 | Moderna, Inc. | $203,200 | 0.2% | NEW | 15.9 | |
| 75 | EXXON MOBIL CORP | $202,574 | 0.2% | -30% | 61.8 | |
| 76 | ASURE SOFTWARE INC | $202,100 | 0.2% | +0% | — | |
| 77 | Apyx Medical Corp | $154,980 | 0.1% | -51% | 19.3 | |
| 78 | AIRGAIN INC | $121,000 | 0.1% | +0% | 19.2 | |
| 79 | OptimizeRx Corp | $99,902 | 0.1% | -9% | 51.3 | |
| 80 | PUMA BIOTECHNOLOGY, INC. | $79,875 | 0.1% | +0% | 52.5 | |
| 81 | ROCKWELL MEDICAL, INC. | $62,855 | 0.1% | +4% | 20.5 | |
| 82 | IRIDEX CORP | $55,853 | 0.1% | +34% | 24.3 | |
| 83 | Pulmonx Corp | $52,890 | 0.1% | -16% | 23.9 | |
| 84 | SOPHiA GENETICS SA | $51,975 | 0.1% | +0% | — | |
| 85 | DYADIC INTERNATIONAL INC | $39,401 | 0.0% | -86% | — | |
| 86 | ACCURAY INC | $20,375 | 0.0% | -39% | 22.7 |
New Positions (4)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for PERKINS CAPITAL MANAGEMENT INC including:
Track PERKINS CAPITAL MANAGEMENT INC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for PERKINS CAPITAL MANAGEMENT INC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: PERKINS CAPITAL MANAGEMENT INC
13F Pro is an AI hedge fund tracker and stock research platform. For PERKINS CAPITAL MANAGEMENT INC (SEC CIK: 884300), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in PERKINS CAPITAL MANAGEMENT INC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.